Beyond the Bedroom: Is the ‘Blue Pill’ Cancer’s New Weapon? A Radiation Oncologist's Shocking Discovery

Send us Fan Mail In this groundbreaking episode, we explore the revolutionary shift in oncology: repurposing PDE5 inhibitors—like sildenafil and tadalafil—from simple urological treatments into powerful multi-targeted anticancer adjuvants. We dive deep into the science of how these agents transform the immune system’s response by dismantling the "immunosuppressive niche" that protects tumors, effectively reprogramming myeloid cells and reversing "immune exclusion" to allow life-saving T-cells...